Form 4 for HCA HCA Healthcare
Accepted 2024-02-02 00:00:00 ET · period of report 2024-01-31 · accession 0001209191-24-002732 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-02 | 2024-02-01 | HCA | Torres Kathryn A. | SVP-Payer Contracting, Align | M - OptEx | $184.24 | +13.0K | 27.6K | +89% | +$2.39M |
| D | 2024-02-02 | 2024-01-31 | HCA | Torres Kathryn A. | SVP-Payer Contracting, Align | S - Sale+OE | $307.00 | -3,861 | 15.9K | -20% | -$1.19M |
| D | 2024-02-02 | 2024-02-01 | HCA | Torres Kathryn A. | SVP-Payer Contracting, Align | F - Tax | $314.66 | -9,268 | 19.6K | -32% | -$2.92M |
| D | 2024-02-02 | 2024-01-31 | HCA | Torres Kathryn A. | SVP-Payer Contracting, Align | A - Grant | $0.00 | +4,402 | 4,402 | New | $0 |
| DM | 2024-02-02 | 2024-02-01 | HCA | Torres Kathryn A. | SVP-Payer Contracting, Align | M - OptEx | $0.00 | -13.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-01 | M | A | 4,771 | $145.24 | 20,670 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-01 | M | A | 1,263 | $253.30 | 28,893 | D | — | — | |
| 3 | Common | Common Stock | 2024-01-31 | S | D | 3,861 | $307.00 | 15,899 | D | — | — | |
| 4 | Common | Common Stock | 2024-02-01 | F | D | 9,268 | $314.66 | 19,625 | D | — | — | |
| 5 | Common | Common Stock | 2024-02-01 | M | A | 4,185 | $173.12 | 24,855 | D | — | — | |
| 6 | Common | Common Stock | 2024-02-01 | M | A | 2,775 | $236.61 | 27,630 | D | — | — | |
| 7 | Derivative | Stock Appreciation Right | 2024-01-31 | A | A | 4,402 | $0.00 | 4,402 | D | $304.90 · 2025-01-31 to 2034-01-31 | 4,402 Common Stock | (F1) The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025. |
| 8 | Derivative | Stock Appreciation Right | 2024-02-01 | M | D | 2,775 | $0.00 | 2,775 | D | $236.61 · — to 2032-01-28 | 2,775 Common Stock | (F4) The stock appreciation rights vest in four equal annual installments beginning on January 28, 2023. |
| 9 | Derivative | Stock Appreciation Right | 2024-02-01 | M | D | 1,263 | $0.00 | 3,789 | D | $253.30 · — to 2033-01-30 | 1,263 Common Stock | (F5) The stock appreciation rights vest in four equal annual installments beginning on January 30, 2024. |
| 10 | Derivative | Stock Appreciation Right | 2024-02-01 | M | D | 4,185 | $0.00 | 4,185 | D | $173.12 · — to 2031-02-03 | 4,185 Common Stock | (F3) The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022. |
| 11 | Derivative | Stock Appreciation Right | 2024-02-01 | M | D | 4,771 | $0.00 | 0 | D | $145.24 · — to 2030-01-29 | 4,771 Common Stock | (F2) The stock appreciation rights vested in four equal annual installments beginning on January 29, 2021. |